Parkside Financial Bank & Trust Coherus Bio Sciences, Inc. Transaction History

Parkside Financial Bank & Trust

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$3.74 - $5.45 $916 - $1,335	-245 Reduced 90.74%	25 $0
Q2 2023 Aug 15, 2023	BUY	$3.79 - $8.3 $943 - $2,066	249 Added 1185.71%	270 $1,000
Q1 2023 May 04, 2023	SELL	$5.89 - $10.52 $376 - $673	-64 Reduced 75.29%	21 $0
Q4 2022 Feb 13, 2023	SELL	$5.69 - $10.07 $580 - $1,027	-102 Reduced 54.55%	85 $0
Q3 2022 Nov 01, 2022	BUY	$7.17 - $13.87 $265 - $513	37 Added 24.67%	187 $2,000
Q2 2022 Jul 13, 2022	SELL	$5.86 - $13.23 $281 - $635	-48 Reduced 24.24%	150 $1,000
Q1 2022 May 13, 2022	SELL	$10.92 - $16.41 $196 - $295	-18 Reduced 8.33%	198 $3,000
Q4 2021 Feb 14, 2022	BUY	$15.81 - $18.99 $31 - $37	2 Added 0.93%	216 $3,000
Q3 2021 Oct 29, 2021	BUY	$12.68 - $17.79 $88 - $124	7 Added 3.38%	214 $3,000
Q2 2021 Aug 06, 2021	BUY	$12.95 - $15.41 $518 - $616	40 Added 23.95%	207 $3,000
Q4 2020 Feb 09, 2021	BUY	$16.56 - $18.94 $1,771 - $2,026	107 Added 178.33%	167 $3,000
Q3 2020 Nov 06, 2020	BUY	$17.41 - $19.89 $1,044 - $1,193	60 New	60 $1,000

136

78M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $86.3M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Parkside Financial Bank & Trust with notifications on news.